Handelsavisen
prelaunch
Companies Healthcare EKTAY.O
EK
EKTAY.O NASDAQ Health Care Equipment & Supplies

Elekta AB (publ)

$5,09
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,9B USD
P/E
EV / Rev
0,4x
Div yield
5,58 %
Op margin
3,0 %
ROE
-4,0 %
Net margin
-1,6 %
Debt / equity
1,03
Beta
52w range
Volume
5,3k
Day range
$4,82–$4,88
Prev close
$4,90
Open
$4,82
Next earnings
Ex-dividend
TR 1Y
About

Elekta AB (publ) operates in the Health Care Equipment & Supplies industry, providing radiation therapy systems and software for cancer treatment.

Business. Elekta AB (publ) is a health care equipment and supplies company that operates within the medical device industry. The firm is headquartered in Sweden and is primarily listed on the NASDAQ under the ticker symbol EKTAY.O. Specific details regarding the company's operating segments and geographic revenue mix are not provided in the available data. Consequently, the business is described at the industry level as a provider of health care equipment and supplies.

Classification85 %
SectorHealth Care
Industry groupHealth Care Equipment & Supplies
Generated · model-assisted
Sell-side consensus
HOLD16 analysts
6 buy3 hold7 sell
Avg 12m price target57,50

Analyst recommendations

16 analysts · consensus Hold
Buy6
Hold3
Sell7
12-month price target
57,50
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
16 analysts · indicative
Ownership
PNC Investments LLC
largest disclosed fund holder
Profitability
-4,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning EKTAY.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to EKTAY.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Elekta AB (publ) is a health care equipment and supplies company that operates within the medical device industry. The firm is headquartered in Sweden and is primarily listed on the NASDAQ under the ticker symbol EKTAY.O. Specific details regarding the company's operating segments and geographic revenue mix are not provided in the available data. Consequently, the business is described at the industry level as a provider of health care equipment and supplies.

    Classification85 %
    SectorHealth Care
    Industry groupHealth Care Equipment & Supplies
    AI synthesis
    GENERATED

    Elekta’s capital structure is characterized by significant leverage and tight liquidity. The company reports total equity of SEK 7.1 billion against total liabilities of SEK 19.9 billion, resulting in a debt-to-equity ratio of 1.03. Long-term debt stands at SEK 7.3 billion, while cash and equivalents are limited to SEK 2.3 billion, leading to a negative net cash position. The current ratio of 0.87 indicates that current liabilities exceed current assets, signaling medium liquidity risk. The market capitalization is SEK 1.78 billion, implying a substantial discount to book value with a price-to-book ratio of 0.25.

    Profitability metrics are currently negative, reflecting operational challenges. Net income is -SEK 519 million, yielding a return on equity (ROE) of -4.03% and a return on assets (ROA) of -1.06%. While gross profit is SEK 6.25 billion on revenue of SEK 16.72 billion, operating income is compressed to SEK 239 million, indicating high operating expenses relative to sales. The EV/EBITDA multiple is 12.61, and EV/Revenue is 0.38, suggesting the market prices the company conservatively given its current earnings trajectory.

    Revenue concentration and geographic exposure details are not provided in the available data. The company’s total revenue is SEK 16.72 billion, but specific segment breakdowns or regional contributions are absent from the current snapshot. Consequently, analysis of revenue concentration risk or geographic diversification cannot be performed based on the present information.

    Growth trajectory analysis is limited due to the absence of historical period data. The current financial snapshot provides a single-period view of revenue and net income. Without 5-year annual or 8-quarter quarterly data, it is not possible to assess year-over-year growth rates, revenue trends, or the consistency of earnings performance over time.

    Risk assessment highlights medium liquidity risk and low dilution risk. Key flags indicate that net cash is negative after subtracting total debt, which constrains financial flexibility. The dilution risk is assessed as low, with basic and diluted shares outstanding being identical at 367.1 million, suggesting no immediate significant option or warrant dilution. The primary financial risk stems from the leverage profile and the ability to service debt given the current negative net income.

    Recent events and market sentiment are reflected in analyst estimates. The mean price target is SEK 57.50, with a median of SEK 55.00, significantly higher than the current market price of SEK 4.86. The mean recommendation is 3.06, indicating a neutral to slightly bearish consensus, with 2 strong buys, 4 buys, and 3 holds. No specific filing, news, or transcript observations are provided in the current data set to detail recent corporate actions or strategic announcements.

    Key takeaways
    • The company trades at a deep discount to book value (P/B 0.25) with a market cap of SEK 1.78 billion.
    • Liquidity is constrained with a current ratio of 0.87 and negative net cash position.
    • Profitability is negative with ROE of -4.03% and net income of -SEK 519 million.
    • Analyst consensus suggests upside potential with a mean price target of SEK 57.50.
    • Dilution risk is low with no difference between basic and diluted share counts.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-05-28
    Q1 2026 · Quarter highlights

    Revenue kr 4.76B; Operating income -kr 461.0M.

    Revenuekr 4.76B
    Operating income-kr 461.0M
    Net income-kr 866.0M
    Free cash flow-kr 1.26B
    EPS
    Operating cash flowkr 2.46B
    Financials
    Income statement
    Revenuekr 4.76B
    Gross profitkr 1.90B
    Operating income-kr 461.0M
    Net income-kr 866.0M
    Margins
    Gross margin39.9%
    Operating margin-9.7%
    Net margin-18.2%
    FCF margin-26.4%
    Balance sheet
    Total assetskr 26.95B
    Total liabilitieskr 19.86B
    Total equitykr 7.10B
    Cash & equivalentskr 3.19B
    Long-term debtkr 7.33B
    Cash flow
    Operating cash flowkr 2.46B
    CapEx-kr 1.07B
    Free cash flow-kr 1.26B
    SBC
    P&L flow · revenue → net income
    Revenue kr 4.76BOperating costs kr 5.22BTax kr 405.0MNet income kr 866.0M
    Highlights
    • Revenue kr 4.76B
    • Operating income -kr 461.0M
    • Net margin -18.2%

    Valuation TTM

    Market price
    $5,09
    Market cap
    $1.78B
    Enterprise value
    $6.82B
    P/E
    Non-GAAP P/E
    EV / Revenue
    0.4x
    EV / Op income
    12.6x
    EV / OCF
    2.8x
    P / B
    0.2x
    P / Tangible book
    0.2x
    Tangible book
    $7.10B
    Net cash
    -$5.04B
    Current ratio
    0.9
    Debt / equity
    1.0
    ROA
    -1.1%
    ROE
    -4.0%
    Cash conversion
    -862.0%
    CapEx / revenue
    -6.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution16 analysts
    Strong buy2
    Buy4
    Hold3
    Sell5
    Strong sell2
    12-month price target$57,50 · Median $55,00
    Low $41,00High $90,00
    Operating income · consensus2,2B SEK
    EPS surprise
    −36,6 %
    reported vs consensus · miss
    Revenue surprise
    −3,0 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$41,00
    Mean$57,50
    Median$55,00
    High$90,00
    Spot$5,09
    +1029.7 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin3,0 %Below median
    Net Margin-1,6 %Below median
    ROE-4,0 %Below median
    Capex / Rev-6,0 %Below median
    D/E1,03Bottom quartile
    Cash Conv-8,62Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Return On Equity
      net_income / total_equity
    • Enterprise Value
      market_cap - net_cash
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    Source documents
    • Elekta AB (publ) Market data — financials · 2026-07-24
    • Elekta AB (publ) Market data — analyst estimates · 2026-07-24
    • Elekta AB (publ) Market data — ESG · 2026-07-24

    Ownership & reference

    Top holders

    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    — missing data

    Short positioning

    3.7Kshares short+142.1% vs prior
    1days to cover
    74fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    EKTAY.PKCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-05-28 06:31 UTCEARNINGSQuarterly results — Q1 2026 Revenue SEK 4.76B · Net SEK -866.0M
    2026-05-28 06:31 UTCEARNINGSAnnual results — FY 2026 Revenue SEK 16.72B · Net SEK -519.0M
    2026-03-05 06:30 UTCEARNINGSQuarterly results — Q4 2025 Revenue SEK 4.24B · Net SEK 9.0M
    2025-11-26 06:30 UTCEARNINGSQuarterly results — Q3 2025 Revenue SEK 4.07B · Net SEK 230.0M
    2025-05-28 06:30 UTCEARNINGSAnnual results — FY 2025 Revenue SEK 18.02B · Net SEK 236.0M
    2025-02-21 06:30 UTCEARNINGSQuarterly results — Q4 2024 Revenue SEK 4.70B · Net SEK 341.0M
    2024-11-27 06:30 UTCEARNINGSQuarterly results — Q3 2024 Revenue SEK 4.34B · Net SEK 211.0M
    2024-08-28 06:30 UTCEARNINGSQuarterly results — Q2 2024 Revenue SEK 3.83B · Net SEK 71.0M
    2024-06-05 06:30 UTCEARNINGSAnnual results — FY 2024 Revenue SEK 18.12B · Net SEK 1.30B
    2023-05-25 06:34 UTCEARNINGSAnnual results — FY 2023 Revenue SEK 16.87B · Net SEK 943.0M
    2022-05-25 06:38 UTCEARNINGSAnnual results — FY 2022 Revenue SEK 14.55B · Net SEK 1.15B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage